Límites de la propiedad intelectual frente a la monopolización de medicamentos en Colombia
Intellectual property emerges at the moment in which the human being uses his intellect for commercial exploitation, the government enters to regulate such fact through an innovation patent which is commonly used to protect the rights of its author for a period of 20 years, however, this right becom...
- Autores:
-
Duarte Cabarique, Wendy
- Tipo de recurso:
- Trabajo de grado de pregrado
- Fecha de publicación:
- 2020
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/6422
- Acceso en línea:
- https://hdl.handle.net/11323/6422
https://repositorio.cuc.edu.co/
- Palabra clave:
- Government
Intellectual property
Medication
Monopoly
Patent
Pharmaceutical industry
Gobierno
Industria farmacéutica
Medicamento
Monopolio
Propiedad intelectual
- Rights
- openAccess
- License
- Attribution-NonCommercial-ShareAlike 4.0 International
| Summary: | Intellectual property emerges at the moment in which the human being uses his intellect for commercial exploitation, the government enters to regulate such fact through an innovation patent which is commonly used to protect the rights of its author for a period of 20 years, however, this right becomes a problem when the protected element is a medicine, because it represents a barrier for the consumer who due to the high cost cannot access it. Besides, being protected by a patent prevents the use of a generic drug until the protection period has elapsed. This problem has been seen as a monopoly of the pharmaceutical industry, because the patent grants the right to commercialize the medicine without competition and without price regulation, under the premise that an investigation is expensive, and that money must be recovered by the investigator. |
|---|